Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak

被引：0
|
作者：
Massimo Nicolò
Lorenzo Ferro Desideri
Matteo Bassetti
Carlo Enrico Traverso
机构：
[1] University Eye Clinic of Genoa,IRCCS Ospedale Policlinico San Martino
[2] University of Genoa,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI)
[3] Macula Onlus Foundation,Infectious Diseases Clinic, Department of Health Sciences
[4] University of Genova and Ospedale Policlinico San Martino- IRCCS Per L’Oncologia,undefined
来源：
International Ophthalmology | 2021年 / 41卷
关键词：
Hydroxychloroquine; Chloroquine; Retina; Retinal safety; COVID-19; Coronavirus; SARCoV-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：719 / 725
页数：6
相关论文
共 50 条
  • [41] Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
    Cortegiani, Andrea
    Ippolito, Mariachiara
    Ingoglia, Giulia
    Iozzo, Pasquale
    Giarratano, Antonino
    Einav, Sharon
    JOURNAL OF CRITICAL CARE, 2020, 59 : 176 - 190
  • [42] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li
    Cheng Cui
    Fei Xu
    Jianping Zhao
    Nan Li
    Haichao Li
    Tianbing Wang
    Hua Zhang
    Na Liu
    Yudong Wei
    Xiaoye Niu
    Yan Xu
    Jianping Dong
    Xueting Yao
    Xiaohong Wang
    Yahong Chen
    Haiyan Li
    Chunli Song
    Jie Qiao
    Dongyang Liu
    Ning Shen
    Science China Life Sciences, 2021, 64 : 660 - 663
  • [43] Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic
    Dauner, Daniel G.
    Dauner, Kim Nichols
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2021, 61 (03) : 293 - 298
  • [44] Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
    Chen, Xuesong
    Geiger, Jonathan D.
    CELLULAR SIGNALLING, 2020, 73
  • [45] Reply Letter - Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
    Meo, S. A.
    Klonoff, D. C.
    Akram, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (13) : 4445 - 4445
  • [46] Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
    Babayeva, Mariana
    Loewy, Zvi
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 531 - 542
  • [47] Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
    Hernandez, Adrian V.
    Roman, Yuani M.
    Pasupuleti, Vinay
    Barboza, Joshuan J.
    White, C. Michael
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (04) : W78 - W79
  • [48] Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
    Shankar, Pathiyil
    Palaian, Subish
    Gulam, Shabaz
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (01): : 4 - 10
  • [49] Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Ibanez, Sebastian
    Martinez, Oriela
    Valenzuela, Francisca
    Silva, Francisco
    Valenzuela, Omar
    CLINICAL RHEUMATOLOGY, 2020, 39 (08) : 2461 - 2465
  • [50] Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery
    Chen, Yao
    Li, Mei-Xiu
    Lu, Guo-Dong
    Shen, Han-Ming
    Zhou, Jing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1538 - 1546
12345